Submission of Matters to a Vote of Security Holders (Form 8-K)

On June 22, 2021, Virios Therapeutics, Inc. (the 'Company') held its 2021 Annual Meeting of Stockholders (the 'Annual Meeting'). Present at the Annual Meeting in person or by proxy were holders of 4,757,922 shares of common stock of the Company, representing 57.11% of the voting power of the shares of common stock of the Company as of the close of business on April 26, 2021, the record date for the Annual Meeting, and constituting a quorum for the transaction of business. All matters voted upon at the Annual Meeting were approved with the required votes. The matters that were voted upon at the Annual Meeting, and the number of votes cast for, withheld or against, as well as the number of abstentions and broker non-votes, as to each such matter are set forth below.

1. Election of five Directors.

The following seven nominees were elected to serve as directors of the Company, with the following votes tabulated:

2. Ratification of the appointment of Dixon Hughes Goodman, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021.

The appointment of Dixon Hughes Goodman, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021 was ratified, with the following votes tabulated:

2